scholarly article | Q13442814 |
P2093 | author name string | Aymeric de Montfort | |
Bachra Rokbi | |||
Florence Boudet | |||
Catherine Berry | |||
Vincent Pavot | |||
Valérie Lecouturier | |||
Arnaud Donadieu | |||
Jon Heinrichs | |||
Nicolas Jackson | |||
P2860 | cites work | Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation. | Q55024075 |
Clinical Features of Guillain-Barré Syndrome With vs Without Zika Virus Infection, Puerto Rico, 2016. | Q55084445 | ||
Evolution of Two Major Zika Virus Lineages: Implications for Pathology, Immune Response, and Vaccine Development | Q56000988 | ||
Critical role of CD4 T cells and IFNγ signaling in antibody-mediated resistance to Zika virus infection | Q56341683 | ||
Zika virus vaccines | Q56354521 | ||
Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine | Q57008172 | ||
CD4+ T cells promote humoral immunity and viral control during Zika virus infection | Q61053646 | ||
Immunogenicity and protection conferred by an optimized purified inactivated Zika vaccine in mice | Q63248468 | ||
Use of a Blockade-of-Binding ELISA and Microneutralization Assay to Evaluate Zika Virus Serostatus in Dengue-Endemic Areas | Q92492602 | ||
Zika virus. I. Isolations and serological specificity | Q22240545 | ||
Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study | Q23012849 | ||
Phylogeny of Zika Virus in Western Hemisphere, 2015 | Q24047862 | ||
Transmission of Zika Virus Through Sexual Contact with Travelers to Areas of Ongoing Transmission — Continental United States, 2016 | Q24261160 | ||
Zika Virus: New Clinical Syndromes and Its Emergence in the Western Hemisphere | Q24261248 | ||
Zika Virus | Q24261255 | ||
Vaccine protection against Zika virus from Brazil | Q25165129 | ||
Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys | Q26248722 | ||
Zika viral dynamics and shedding in rhesus and cynomolgus macaques | Q27087751 | ||
Zika Virus Infection as a Cause of Congenital Brain Abnormalities and Guillain–Barré Syndrome: Systematic Review | Q28114477 | ||
Development of a Zika Virus Infection Model in Cynomolgus Macaques | Q28223377 | ||
Global risk model for vector-borne transmission of Zika virus reveals the role of El Niño 2015 | Q28566466 | ||
Zika Virus Persistence in the Central Nervous System and Lymph Nodes of Rhesus Monkeys | Q29587262 | ||
Rapid development of a DNA vaccine for Zika virus | Q34542032 | ||
Correlates of protection induced by vaccination | Q37750121 | ||
Antibody-based assay discriminates Zika virus infection from other flaviviruses | Q38157718 | ||
An update on Zika vaccine developments | Q38158670 | ||
Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine - Preliminary Report. | Q41924763 | ||
Evaluation of Infrared Thermometry in Cynomolgus Macaques (Macaca fascicularis). | Q42002161 | ||
Optimization of a human IgG B-cell ELISpot assay for the analysis of vaccine-induced B-cell responses | Q43829673 | ||
Intranasal infection and contact transmission of Zika virus in guinea pigs | Q44170191 | ||
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials | Q45323629 | ||
Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials | Q45323630 | ||
Durability and correlates of vaccine protection against Zika virus in rhesus monkeys. | Q47315490 | ||
Generation of memory B cells and their reactivation. | Q52583259 | ||
P921 | main subject | Zika virus | Q202864 |
P304 | page(s) | 19 | |
P577 | publication date | 2020-03-12 | |
P1433 | published in | NPJ Vaccines | Q30275609 |
P1476 | title | An optimized purified inactivated Zika vaccine provides sustained immunogenicity and protection in cynomolgus macaques | |
P478 | volume | 5 |
Search more.